Pharos iBio
Pharos iBio is a new drug development company that develops treatments for rare
and refractory diseases using a new drug development platform based on big data
and AI technology.
Pharos Therapeutics is a parent company.
Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.
Pharos iBio is a new drug development company that develops treatments for rare
and refractory diseases using a new drug development platform based on big data
and AI technology.
Pharos Therapeutics is a parent company.